ID
25759
Description
Study ID: 101468/191 Clinical Study ID: SKF-101468/191 Study Title:A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Ropinirole in Subjects with Restless Legs Syndrome (RLS) Suffering from Periodic Leg Movements of Sleep (PLMS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Restless Legs Syndrome
Keywords
Versions (1)
- 9/17/17 9/17/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
September 17, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Form D (Form 23)
GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Form D (Form 23)
Description
Form D
Description
Certified cause of death
Data type
text
Description
Date of death
Data type
date
Description
Post-mortem
Data type
text
Description
Post-mortem findings
Data type
text
Description
Reporting Physician´s Signature
Data type
text
Description
Date
Data type
date